Matches in Wikidata for { <http://www.wikidata.org/entity/Q57098450> ?p ?o ?g. }
Showing items 1 to 53 of
53
with 100 items per page.
- Q57098450 description "article scientifique publié en 2012" @default.
- Q57098450 description "im Februar 2012 veröffentlichter wissenschaftlicher Artikel" @default.
- Q57098450 description "wetenschappelijk artikel" @default.
- Q57098450 description "наукова стаття, опублікована в лютому 2012" @default.
- Q57098450 name "The bivalent ligand approach leads to highly potent and selective acylguanidine-type histamine H₂ receptor agonists" @default.
- Q57098450 name "The bivalent ligand approach leads to highly potent and selective acylguanidine-type histamine H₂ receptor agonists" @default.
- Q57098450 type Item @default.
- Q57098450 label "The bivalent ligand approach leads to highly potent and selective acylguanidine-type histamine H₂ receptor agonists" @default.
- Q57098450 label "The bivalent ligand approach leads to highly potent and selective acylguanidine-type histamine H₂ receptor agonists" @default.
- Q57098450 prefLabel "The bivalent ligand approach leads to highly potent and selective acylguanidine-type histamine H₂ receptor agonists" @default.
- Q57098450 prefLabel "The bivalent ligand approach leads to highly potent and selective acylguanidine-type histamine H₂ receptor agonists" @default.
- Q57098450 P1433 Q57098450-FEE3B1BD-ADB5-4171-96CC-F100E8E6BFF2 @default.
- Q57098450 P1476 Q57098450-AB0E0A97-A6E2-46C7-A261-9FF53D453BEA @default.
- Q57098450 P2093 Q57098450-5C2F847A-3CFD-4C16-80FE-8DBC517B72A4 @default.
- Q57098450 P2093 Q57098450-5D05A18C-CFBC-4B23-9469-785048080025 @default.
- Q57098450 P2093 Q57098450-6D77B5A2-50AB-4FEE-9C34-CB7A33303EAC @default.
- Q57098450 P2093 Q57098450-6EFE0DA9-8240-4558-A3D1-189A2889586E @default.
- Q57098450 P2093 Q57098450-8B2BCEBE-775C-42E8-BDD5-BD86D6C07097 @default.
- Q57098450 P2093 Q57098450-93B3608E-3D9D-4312-A834-57D5FD818917 @default.
- Q57098450 P2093 Q57098450-A7640012-A427-40BB-BAF8-49F9B26E26C2 @default.
- Q57098450 P2093 Q57098450-B7263C71-FB12-4186-8938-6A90F64E8AFD @default.
- Q57098450 P2093 Q57098450-E2A262EA-55AE-44F6-9390-4C3BD573375F @default.
- Q57098450 P2093 Q57098450-FF71A1AE-FC77-47EF-9407-E51DDD1127B6 @default.
- Q57098450 P304 Q57098450-F5F71E19-2387-4D37-A9BB-EA4CFB8B960E @default.
- Q57098450 P31 Q57098450-876B6B9C-72D8-4126-92F1-28B8D052C4A2 @default.
- Q57098450 P356 Q57098450-E80B697C-CEE7-46FB-A2C3-9D671943BE41 @default.
- Q57098450 P407 Q57098450-580BDA03-9BED-46A2-98DB-A835CA72E955 @default.
- Q57098450 P433 Q57098450-16DD5124-CF16-4319-94E8-CD69DBDE65E0 @default.
- Q57098450 P478 Q57098450-48099D9E-41E6-4505-BA8F-431219A15D96 @default.
- Q57098450 P577 Q57098450-4E91C498-BA02-4705-9854-E67C00B1E53E @default.
- Q57098450 P698 Q57098450-60C5C788-02F4-4B38-A5B0-447D39BC92A2 @default.
- Q57098450 P356 JM201128Q @default.
- Q57098450 P698 22216892 @default.
- Q57098450 P1433 Q900316 @default.
- Q57098450 P1476 "The bivalent ligand approach leads to highly potent and selective acylguanidine-type histamine H₂ receptor agonists" @default.
- Q57098450 P2093 "Anja Spickenreither" @default.
- Q57098450 P2093 "Armin Buschauer" @default.
- Q57098450 P2093 "Günther Bernhardt" @default.
- Q57098450 P2093 "Irena Brunskole" @default.
- Q57098450 P2093 "Miroslaw Lopuch" @default.
- Q57098450 P2093 "Nicole Kagermeier" @default.
- Q57098450 P2093 "Roland Seifert" @default.
- Q57098450 P2093 "Sigurd Elz" @default.
- Q57098450 P2093 "Stefan Dove" @default.
- Q57098450 P2093 "Tobias Birnkammer" @default.
- Q57098450 P304 "1147-60" @default.
- Q57098450 P31 Q13442814 @default.
- Q57098450 P356 "10.1021/JM201128Q" @default.
- Q57098450 P407 Q1860 @default.
- Q57098450 P433 "3" @default.
- Q57098450 P478 "55" @default.
- Q57098450 P577 "2012-02-09T00:00:00Z" @default.
- Q57098450 P698 "22216892" @default.